Related Experiment Videos
Pediatric heart allocation and transplantation in Eurotransplant
Jacqueline M Smits1, Josef Thul, Michel De Pauw
1Eurotransplant International Foundation, Leiden, The Netherlands.
Insights
Pediatric heart transplant allocation in Eurotransplant has improved, decreasing waiting list deaths and enhancing survival rates. Advances in medical management and mechanical support offer better outcomes for children awaiting heart transplants.
Area of Science:
- Cardiology
- Transplantation Medicine
- Pediatric Critical Care
Background:
- Pediatric heart transplantation (HT) is a critical intervention for end-stage heart failure in children.
- Allocation policies in Eurotransplant (ET) have undergone significant evolution to optimize patient outcomes and organ utilization.
- Pediatric HT constitutes 6% of the total transplant volume within the Eurotransplant region.
Purpose of the Study:
- To analyze the trends in pediatric heart transplant allocation, waiting list mortality, and post-transplant survival within Eurotransplant.
- To evaluate the impact of evolving allocation strategies and medical advancements on pediatric heart transplant outcomes.
Main Methods:
- Retrospective analysis of pediatric heart transplant data from the Eurotransplant registry.
- Examination of waiting list mortality rates stratified by age group.
- Assessment of survival rates at 1 and 3 years post-transplantation over different time periods.
Main Results:
- Waiting list death rates for pediatric heart transplant candidates decreased from 25% in 1997 to 18% in 2011.
- First-year post-listing mortality varied by age: 32% for infants (<12 months), 20% for children (1-10 years), and 15% for older children (11-15 years).
- One-year post-transplant survival improved from 83% to 89%, and 3-year survival increased from 81% to 85% over a decade.
Conclusions:
- Evolving pediatric heart allocation policies in Eurotransplant have successfully reduced waiting list mortality.
- Significant improvements in post-transplant survival underscore the effectiveness of enhanced medical management and mechanical circulatory support.
- The overall outlook for pediatric patients requiring heart transplantation has considerably improved due to these advancements.
Abstract:
Pediatric heart allocation in Eurotransplant (ET) has evolved over the past decades to better serve patients and improve utilization. Pediatric heart transplants (HT) account for 6% of the annual transplant volume in ET. Death rates on the pediatric heart transplant waiting list have decreased over the years, from 25% in 1997 to 18% in 2011. Within the first year after listing, 32% of all infants (<12 months), 20% of all children aged 1-10 years, and 15% of all children aged 11-15 years died without having received a heart transplant. Survival after transplantation improved over the years, and in almost a decade, the 1-year survival went from 83% to 89%, and the 3-year rates increased from 81% to 85%. Improved medical management of heart failure patients and the availability of mechanical support for children have significantly improved the prospects for children on the heart transplant waiting list.